Prescription drug · ANDA
Cisatracurium Besylate NDC 55150-284
Cisatracurium besylate 10 mg/5mL · Injection · Intravenous · Eugia US LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55150-284-10 | 5515002841055150028410 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-284-10) / 5 mL in 1 VIAL, SINGLE-DOSE (55150-284-01)Marketed from Oct 27, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cisatracurium Besylate
- Generic name (nonproprietary)
- cisatracurium besylate
- Active ingredients
- Cisatracurium besylate — 10 mg/5mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- Eugia US LLCNDC labeler code 55150
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209665
- Marketing start
- Listing expires
- Other FDA classes
- Neuromuscular Nondepolarizing Blockade (Physiologic effect)
- Identifiers
- Product ID 55150-284_d40d8c7d-32a9-4518-9043-766790c1037cSPL ID d40d8c7d-32a9-4518-9043-766790c1037cSPL set ID 2cb05c7e-6228-4e2d-a270-7659e3db3fa7RxCUI 199211, 1730194UNII 80YS8O1MBSUPC 0355150286010
- Pharmacologic class
- Nondepolarizing Neuromuscular Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N455150028410followed by a unit qualifier and the quantityPackage 55150-0284-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Cisatracurium besylate injection is indicated: as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the ICU to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older Limitations of Use Cisatracurium besylate injection is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action. Cisatracurium besylate injection is a nondepolarizing neuromuscular blocker indicated: as an adjunct to general anesthe…
Excerpt only. Read the full label for complete information.
About NDC 55150-284
- What is NDC 55150-284?
- 55150-284 is the product NDC for Cisatracurium Besylate, Cisatracurium besylate 10 mg/5mL injection, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cisatracurium Besylate.
- What is the active ingredient?
- Cisatracurium besylate.
- Who is the labeler?
- Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cisatracurium Besylate?
- 34 other product NDCs are listed under this name. See all Cisatracurium Besylate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Cisatracurium Besylate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | Injection, SolutionIntravenous | Avenacy, LLC | 83634-655 | 83634-0655-20 |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-312 | 31722-0312-10 |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-313 | 31722-0313-10 |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-314 | 31722-0314-10 |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-486 | 68083-0486-01 |
| Cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-487 | 68083-0487-01 |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-488 | 68083-0488-01 |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9160 | 00143-9160-10 |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9397 | 00143-9397-10 |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Caplin Steriles Limited | 65145-135 | 65145-0135-0165145-0135-10 |